🇺🇸
United States · US · US:0002-8214_3c2283e6-2844-44d2-a447-579b07e77c27
BASAGLAR
In shortageUNIISPLATC A10AE04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerEli Lilly and Company
CountryUS (United States)
ATC codeA10AE04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1100028214055 SYRINGE in 1 CARTON (0002-8214-05) / 3 mL in 1 SYRINGE (0002-8214-01)
Annotations
UNII (FDA Substance ID)
2ZM8CX04RZ
INSULIN GLARGINE
RxCUI 274783
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Insulin Lispro-aabc Injection
Raw payload (JSON)
{
"unii": {
"unii": "2ZM8CX04RZ",
"rxcui": "274783",
"inchikey": null,
"display_name": "INSULIN GLARGINE",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"0ad21db3-2b1c-4ed9-a687-bdd6a74d0aae": {
"match": "brand_token",
"title": "BASAGLAR KWIKPEN (INSULIN GLARGINE) INJECTION, SOLUTION BASAGLAR TEMPO PEN (INSULIN GLARGINE) INJECTION, SOLUTION [ELI LILLY AND COMPANY]",
"spl_version": "34",
"published_date": "2026-01-23"
}
},
"productid": "0002-8214_3c2283e6-2844-44d2-a447-579b07e77c27",
"productndc": "0002-8214",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "INSULIN GLARGINE",
"shortage_reason": "Insulin Lispro-aabc Injection",
"shortage_status": "current",
"proprietary_name": "BASAGLAR",
"active_ingred_unit": "[iU]/mL",
"application_number": "BLA205692",
"marketing_category": "BLA",
"nonproprietary_name": "Insulin glargine",
"start_marketing_date": "20151216",
"active_numerator_strength": "100"
}Related drugs
Other records sharing ATC code A10AE04.
Access this data programmatically
Query BASAGLAR and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.